Estracyt
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Estracyt, covering 2009-12-11 to 2012-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate [Phase 2]